1[1]Danis RP,Bingaman DP,Yang Y,et al.Inhibition of preretinal And optic nerve head neovascularization in pigs by intravitreal triamcin olone acetonide[J].Ophthalmol,1996,103(12):2099-2104.
3[3]Oamamoto T.Akabane N,Takeuchi S.Vitrectomy for diabetic macu tar edema:the role of posterior vitreous detachment and epimacular membrsne[J].Am J ophthalmol,2001,132(2):369-377.
4[4]Jonas JB.Intraocular availability of triamcinolone acetonide after in travitreal injection[J].Am J Ophthalmol,2004,137(4):560-562.
5[5]Massin P,Audren F,Haouchine B,et al.Intravitreal triamcinolone acetonide for diabetic diffuse macular edema:preliminary results of a prospective controlled trial[J].Ophthalmology,2004,111(2):218 -224.
6[6]Jonas JB,Akkoyun l,Kreissig I,et al.Diffuse diabetic maeular edema treated by intravitreal Triameinolone acetonide:A comparative non randomised study[J].Br J Ophthalmol,2005,89(3):321-326.
7[7]Islam MS,Negi A,Vernon SA.Improved visual acuity and macular thickness 1 week after Intravitreal triamcinolone acetonide for diabet ic macular edema[J].Eye,2005,19(12):1325-1327.
8[8]Krepler K,Ergun E,Sacu S,et al.Intravitreal triamcinolone ace tonide in patients with maeular oedema due to central rentinal vein occlusion[J].Acth Ophthalmol Seam,2005,83(1):71-75.
9[9]Krepler K,Ergune E,Sacu S,et al.Intravitreal triamcinolone ace tonide in patients With macular edema due to branch retianl vein oc clusion[J].Acta Ophthalmol Stand,2005,83(5):600-604.
10[10]Degenring RF,Jonas JB.Intravitrealin injection of triamcinolone acetonide as treatment for chronic uveitls[J].Br J Ophthalmol,2003,87(3):361.
4Sharma S. Levels of evidence and international ophthamology .Can J Ophthalmol, 1997, 32:359-362.
5Sutter FKP, Simpson JM, Gillies MC, et al. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment. Ophthalmology, 2004, 111: 2044-2049.
6Jonas JB, Degenring R. Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular edema. Klin Monatsbl Augenheilkd, 2002, 219: 429-432.
7Jonas JB, Kreissig I, Sofker A. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol, 2003, 121: 57-61.
8Massin P, Audren F, Haouchine B, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema:preliminary results of a prospective controlled trial.Ophthalmology, 2004, 111: 218-224.
9Jonas JB, Hayler JK, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol, 2000, 84:1064-1067.
10Bashshur ZF, Ma'luf RN, Allam S. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion. Arch Ophthalmol, 2004,122: 1137-1140.
4Lacmanovic LV, Petric I. Surgical treatment, clinical outcomes, and complications of traumatic cataract: retrospective study. Croat Med J ,2004;45(3):310-313
5Koenig SB, Ruttum MS, Lewandowski MF, et al. Pseudophakia for traumatic cataracts in children. Ophthalmology ,1993;100:1218-1224
6Cheng ET, Pollard JD, Koch RJ. Effectof landed CO and erbium: YAG laser irradiation on normal and Keloid fibroblasts : a Serum-free Study[J]. Clin Laser Mecl Surg,2003,21 (6) :337 -343.
7Kato A, Kimura H, Okabe K, et al. Feasibility of drug delivery to the posterior pole of the rab- bit eye with an episcleral implant [ J ]. Invest Ophthalmol Vis Sci,2004,45 (1) :238 -244.
8Pelzek C,Lim JI.Diabetic macuar edema:review and update.Ophth Mmol Clin Am,2002,15(4):555-563.
